Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed

Investigating the daily life experiences of patients using Continuous Glucose Monitoring (CGM) can highlight the benefits and barriers in using this system for people with type 1 diabetes (T1D). Semi-structured qualitative interviews were conducted with the caregivers of 10 children aged <9 years...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kağan Ege Karakuş, Sibel Sakarya MD, MPH, Gül Yeşiltepe Mutlu MD, Metehan Berkkan, Serra Muradoğlu MA, Ecem Can MSN, RN, Tuğba Gökçe BSN, Elif Eviz MD, Şükrü Hatun MD
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/552d601abcef4f5db01bbda5719b9c4b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:552d601abcef4f5db01bbda5719b9c4b
record_format dspace
spelling oai:doaj.org-article:552d601abcef4f5db01bbda5719b9c4b2021-12-02T23:33:37ZBenefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed2374-374310.1177/23743735211056523https://doaj.org/article/552d601abcef4f5db01bbda5719b9c4b2021-12-01T00:00:00Zhttps://doi.org/10.1177/23743735211056523https://doaj.org/toc/2374-3743Investigating the daily life experiences of patients using Continuous Glucose Monitoring (CGM) can highlight the benefits and barriers in using this system for people with type 1 diabetes (T1D). Semi-structured qualitative interviews were conducted with the caregivers of 10 children aged <9 years, all of whom had been treated for T1D and had used CGM >6 months. These interviews were analyzed using the content analysis approach and from these interviews, four meta themes emerged: metabolic control, barriers to CGM use, CGM use in daily life, and comparison with fingersticks. Families reported the following as benefits of CGM: pain relief, better hypoglycemia and hyperglycemia management, increased control over diet and social life, reduced worries at school and during the night, and convenience in entrusting the child to the care of others. Cost, concerns related to accuracy and reliability of measurements, insertion, adhesion and removal issues all emerged as barriers to CGM use. The most prominent issue was the economic burden of CGM. Families accept this burden, even though it is challenging, as their experiences in using CGM are positive and they feel that CGM is necessary for T1D management.Kağan Ege KarakuşSibel Sakarya MD, MPHGül Yeşiltepe Mutlu MDMetehan BerkkanSerra Muradoğlu MAEcem Can MSN, RNTuğba Gökçe BSNElif Eviz MDŞükrü Hatun MDSAGE PublishingarticleMedicine (General)R5-920ENJournal of Patient Experience, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Kağan Ege Karakuş
Sibel Sakarya MD, MPH
Gül Yeşiltepe Mutlu MD
Metehan Berkkan
Serra Muradoğlu MA
Ecem Can MSN, RN
Tuğba Gökçe BSN
Elif Eviz MD
Şükrü Hatun MD
Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
description Investigating the daily life experiences of patients using Continuous Glucose Monitoring (CGM) can highlight the benefits and barriers in using this system for people with type 1 diabetes (T1D). Semi-structured qualitative interviews were conducted with the caregivers of 10 children aged <9 years, all of whom had been treated for T1D and had used CGM >6 months. These interviews were analyzed using the content analysis approach and from these interviews, four meta themes emerged: metabolic control, barriers to CGM use, CGM use in daily life, and comparison with fingersticks. Families reported the following as benefits of CGM: pain relief, better hypoglycemia and hyperglycemia management, increased control over diet and social life, reduced worries at school and during the night, and convenience in entrusting the child to the care of others. Cost, concerns related to accuracy and reliability of measurements, insertion, adhesion and removal issues all emerged as barriers to CGM use. The most prominent issue was the economic burden of CGM. Families accept this burden, even though it is challenging, as their experiences in using CGM are positive and they feel that CGM is necessary for T1D management.
format article
author Kağan Ege Karakuş
Sibel Sakarya MD, MPH
Gül Yeşiltepe Mutlu MD
Metehan Berkkan
Serra Muradoğlu MA
Ecem Can MSN, RN
Tuğba Gökçe BSN
Elif Eviz MD
Şükrü Hatun MD
author_facet Kağan Ege Karakuş
Sibel Sakarya MD, MPH
Gül Yeşiltepe Mutlu MD
Metehan Berkkan
Serra Muradoğlu MA
Ecem Can MSN, RN
Tuğba Gökçe BSN
Elif Eviz MD
Şükrü Hatun MD
author_sort Kağan Ege Karakuş
title Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
title_short Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
title_full Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
title_fullStr Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
title_full_unstemmed Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
title_sort benefits and drawbacks of continuous glucose monitoring (cgm) use in young children with type 1 diabetes: a qualitative study from a country where the cgm is not reimbursed
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/552d601abcef4f5db01bbda5719b9c4b
work_keys_str_mv AT kaganegekarakus benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed
AT sibelsakaryamdmph benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed
AT gulyesiltepemutlumd benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed
AT metehanberkkan benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed
AT serramuradogluma benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed
AT ecemcanmsnrn benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed
AT tugbagokcebsn benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed
AT elifevizmd benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed
AT sukruhatunmd benefitsanddrawbacksofcontinuousglucosemonitoringcgmuseinyoungchildrenwithtype1diabetesaqualitativestudyfromacountrywherethecgmisnotreimbursed
_version_ 1718374051545612288